Skip to content

Piramal Pharma trades lower by over 2% after Q1 earnings

EBITDA margin for the June quarter grew to 10 percent up from 6 percent in Q1FY23.

Read More

​ EBITDA margin for the June quarter grew to 10 percent up from 6 percent in Q1FY23. EBITDA margin for the June quarter grew to 10 percent up from 6 percent in Q1FY23.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish